Amicus Therapeutics, Inc.FOLDNASDAQ
Loading
Operating Income ScalingExpanding
Percentile Rank100
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$34.49M
↑ 118% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
$-194.01M
Historical baseline
PeriodValueYoY Change
2025$34.49M+38.7%
2024$24.88M+132.2%
2023$-77.21M+63.6%
2022$-212.12M-2.8%
2021$-206.43M+16.4%
2020$-247.00M+18.8%
2019$-304.04M+7.5%
2018$-328.78M+25.6%
2017$-441.99M-143.0%
2016$-181.89M-